A2 (N-Benzylpiperazine) a New Drug of Abuse in Sweden

Journal of Analytical Toxicology

Volumn 28, Issue 1, 2004, Pages 67-70

  Wikström, Maria ^a   Holmgren, Per ^a   Ahlner, Johan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; N BENZYLPIPERAZINE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

APPARATUS; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CHEMICAL STRUCTURE; DRUG ABUSE; FORENSIC PATHOLOGY; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; POLICE; SWEDEN; TOXICOLOGY; URINALYSIS;

ANIMALIA;

EID: 1642540078     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.1.67     Document Type: Article

References (9)

1. K. Magyar. Pharmacokinetic aspects of the mode of action of EGYPT475; a new antidepressant agent. Pol. J. Pharmacol. Pharm. 39: 107-112 (1987).
2. K. Tekes, L. Tothfalusi, B. Malomvolgi, F. Herman, and K. Magyar. Studies on the biochemical mode of action of EGYPT-47, a new antidepressant. Pol. J. Pharmacol. Pharm. 39: 203-211 (1987).
3. A.D. Munro-Faure, A.W. Peck, C. Pullin, and P.A. Young. Detection of dexamphetamine-like activity in man. A comparison of several tests. J. Pharm. Chim. (Paris) 2: 228-229 (1971).
4. C. Bye, A.D. Munro-Faure, A.W. Peck, and P.A. Young. Comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. Eur. J. Clin. Pharmacol. 6: 163-169 (1973).
5. H. Campbell, W. Cline, M. Evans, J. Lloyd, and A.W. Peck. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur. J. Clin. Pharmacol. 6: 170-176 (1973).
6. D. de Boer, I.J. Bosman, E. Hidvégi, C. Manzoni, A.A. Benkö, L.J.A.L. dos Reys, and R.A.A. Maes. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci. Int. 121: 47-56 (2001).
7. R.F. Staack, G. Fritschi, and H.H. Maurer. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. J. Chromatogr. B 773: 35-46 (2002).
8. L.A. King and A.J. Poortman van-der Meer. New synthetic drugs in the European Union. Sci. Justice 41: 200-202 (2001).
9. C. Balmelli, H. Kupferschmidt, K. Reutsch, and M. Schneemann. Fatal brain oedema after ingestion of ecstasy and benzylpiperazine. Dtsch. Med. Wochensch. 126: 809-811 (2000).